In September last year, Dr Reddy's Laboratories partnered with Russian Direct Investment Fund to conduct clinical trials of Sputnik V and for its distribution rights in India.
Dr. Reddy's, which partnered with the makers of Sputnik V vaccine to run clinical trials in India, has submitted additional data that was sought by the expert panel.
Chinese-owned Gland Pharma, based in Hyderabad, says it will supply 252 million shots of Sputnik V, adding to more than 100 million doses planned from other Indian manufacturers.
Russia's vaccine, perhaps its biggest scientific breakthrough since Soviet era, won’t change hostility towards Putin among Western govts, but could boost geopolitical clout in other regions.
The industry forecasts exports are set to grow 16% in 2025-26, boosted by surplus domestic production and a drive to push into 26 underserved global markets with strong potential.
Indigenisation level will progressively increase up to 60 percent with key sub-assemblies, electronics and mechanical parts being manufactured locally.
It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.
Bharat Biotech needs to start subcontracting to other vaccine manufacturers like private players or Haffkines and BCG institute at the earliest so more doses can be produced from capacity lying unused!!!!
Bharat Biotech needs to start subcontracting to other vaccine manufacturers like private players or Haffkines and BCG institute at the earliest so more doses can be produced from capacity lying unused!!!!